Menlo Therapeutics's activity chart (see below) currently has 11 price targets and 7 ratings on display.
Analysts' price targets on this stock were met 9.09% of the time, taking 2.64 days on average.
Most recent stock forecast was given by from on 01-Jun-2020. First documented stock forecast 08-Apr-2018.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 01-Jun-2020
$6
6 years 5 months 20 days ago
(01-Jun-2020)
0/1 (0%)
$-164.64 (-96.48%)
Buy Since 13-May-2020
$3
6 years 6 months 8 days ago
(13-May-2020)
0/1 (0%)
$-119.4 (-97.55%)
Buy Since 18-Oct-2019
$2.5
$9
6 years 6 months 9 days ago
(12-May-2020)
0/3 (0%)
$-127.82 (-98.08%)
Hold
$7
8 years 1 months 12 days ago
(09-Oct-2018)
1/1 (100%)
$0.74 (11.82%)
29
Buy Since 06-Sep-2018
$25
8 years 2 months 15 days ago
(06-Sep-2018)
0/1 (0%)
$-524.36 (-95.45%)
What is MNLO (Menlo Therapeutics) average time for price targets to be met?
Which analyst most recently updated their price target on MNLO (Menlo Therapeutics)?
Which analyst has the most public recommendations on MNLO (Menlo Therapeutics)?
Which analyst is the currently most bullish on MNLO (Menlo Therapeutics)?
Which analyst is the currently most reserved on MNLO (Menlo Therapeutics)?